CLS delivered a quarter strong enough to trigger a wave of analyst upgrades. Yet the stock fell 14% on the day results landed. That tension — between what Wall Street's analysts said and what the market did — defines the setup heading into May.
The earnings reaction was brutal in isolation. The stock dropped 12% on April 27 when results arrived after the close, and another leg lower on April 28 pushed the combined decline to 14.5% for the week. The stock closed at CAD $493.22, off roughly 11% across the five sessions. Revenue hit $4.05 billion for the quarter, up nearly 53% year-over-year. The EBITDA margin was 7.6% and net income came in at $212 million. On any fundamental reading, these were strong numbers. The market's verdict was something else entirely.
The analyst response the following day was nearly unanimous in the other direction. JP Morgan maintained Overweight and raised its target to $425. Barclays kept Overweight and lifted to $441. RBC held Outperform and moved its target to $440. Citigroup maintained Buy and raised to $415. Most strikingly, TD Cowen upgraded the stock outright to Buy with a $430 target — the only formal rating upgrade in the batch. Susquehanna was the most bullish, pushing its target to $510 while maintaining Positive. The broad direction was clear: analysts rewarded the print. The Street's analyst return potential now stands at roughly 11%, measured against a $493 stock, which implies most of those freshly-raised targets land in the $420-$510 corridor priced in USD — note that CLS trades in CAD on the TSX, and some analyst targets may be denominated in USD; the upside percentages should be treated directionally. The valuation data points to a P/E of 31.7x, down sharply over the week (off nearly 8x in seven days), while EV/EBITDA compressed to 21.4x — both multiples re-rating lower as the share price fell faster than earnings estimates moved.
Short positioning tells a very subdued story that sits completely outside this week's noise. Short interest is less than 1% of the free float — just 0.99% — and has fallen 16% over the past week alone. The borrow market is loose: availability is effectively unconstrained, with cost to borrow having collapsed to 0.27% from above 1.3% in mid-April. The short score of 27.5 is low and has barely moved all month. This is not a stock that short sellers are building into. The April price drop was driven by investors exiting long positions, not by aggressive new shorting — a meaningful distinction. Availability has eased dramatically alongside the CTB decline, and nothing in the lending market suggests a squeeze risk or an aggressive short thesis building beneath the surface.
The institutional ownership picture shows a stock with heavyweight backing that has generally been adding rather than trimming. BlackRock reported adding over 4.2 million shares as of March 31 — a substantial move. FMR (Fidelity) added nearly 512,000 shares and remains the largest disclosed holder at 6.4% of shares. JP Morgan Asset Management added 408,000 shares. Franklin Resources added 356,000 shares. The notable exception is Whale Rock Capital, which cut its position by over 1.1 million shares as of December — but that data predates the Q1 results by several months. The EPS momentum factor ranks in the 88th percentile on a 30-day view and 85th on a 90-day view, pointing to persistent positive estimate revisions. The EPS surprise rank at the 31st percentile is more modest, suggesting the beat quality this quarter was not exceptional relative to history — which may partly explain the negative initial market reaction despite headline revenue growth.
The next scheduled event is a Q1 2026 Earnings Call on May 19. Between now and then, the question is whether the analyst-driven target raises — all issued the day after the stock's worst session of the month — are enough to attract fresh institutional interest at current levels, or whether the post-earnings gap remains an overhang. Peer behaviour adds context: close comparables FLEX was down 3% on the day but up 2% on the week, while COHR fell over 11% across the week — the sector-wide backdrop was not supportive. FN dropped 8% over five sessions. CLS's underperformance relative to JBL (down 0.9% on the week) stands out. The May 19 call will offer management's first chance to address the market directly following the post-earnings selloff.
See the live data behind this article on ORTEX.
Open CLS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
